カテゴリー： Market Monitor Global, 世界, 医療/バイオ

神経用化学物質のグローバル市場展望 2023年-2029年：一般用医薬品、処方箋医薬品

◆英語タイトル：Nervous System Chemicals Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23DC16491）

◆商品コード：MMG23DC16491
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年12月
◆ページ数：137
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の神経用化学物質市場規模と予測を収録しています。・世界の神経用化学物質市場：売上、2018年-2023年、2024年-2029年
・世界の神経用化学物質市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の神経用化学物質市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「一般用医薬品」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

神経用化学物質のグローバル主要企業は、Pfizer、 Ely Lilly、 Actavis(Teva Pharmaceuticals)、 Mylan(Viatris)、 UCB、 Intellipharmaceutics、 Astrazeneca、 Lundbeck、 Allergan(AbbVie)、 GSK、 Otsuka Pharmaceutical、 Takeda、 Novartis、 Johnson & Johnson、 Eisai、 Kelun Pharmaceutical、 Humanwell Pharmaceutical、 Enhua Pharmaceutical、 Yangzijiang Pharmaceuticalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、神経用化学物質のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の神経用化学物質市場：タイプ別、2018年-2023年、2024年-2029年
世界の神経用化学物質市場：タイプ別市場シェア、2022年
・一般用医薬品、処方箋医薬品

世界の神経用化学物質市場：用途別、2018年-2023年、2024年-2029年
世界の神経用化学物質市場：用途別市場シェア、2022年
・病院、診療所、その他

世界の神経用化学物質市場：地域・国別、2018年-2023年、2024年-2029年
世界の神経用化学物質市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における神経用化学物質のグローバル売上、2018年-2023年
・主要企業における神経用化学物質のグローバル売上シェア、2022年
・主要企業における神経用化学物質のグローバル販売量、2018年-2023年
・主要企業における神経用化学物質のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Pfizer、 Ely Lilly、 Actavis(Teva Pharmaceuticals)、 Mylan(Viatris)、 UCB、 Intellipharmaceutics、 Astrazeneca、 Lundbeck、 Allergan(AbbVie)、 GSK、 Otsuka Pharmaceutical、 Takeda、 Novartis、 Johnson & Johnson、 Eisai、 Kelun Pharmaceutical、 Humanwell Pharmaceutical、 Enhua Pharmaceutical、 Yangzijiang Pharmaceutical

*************************************************************

・調査・分析レポートの概要
神経用化学物質市場の定義
市場セグメント
世界の神経用化学物質市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の神経用化学物質市場規模
世界の神経用化学物質市場規模：2022年 VS 2029年
世界の神経用化学物質市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの神経用化学物質の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の神経用化学物質製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：一般用医薬品、処方箋医薬品
神経用化学物質のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
神経用化学物質の用途別グローバル売上・予測

・地域別市場分析
地域別神経用化学物質市場規模 2022年と2029年
地域別神経用化学物質売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Pfizer、 Ely Lilly、 Actavis(Teva Pharmaceuticals)、 Mylan(Viatris)、 UCB、 Intellipharmaceutics、 Astrazeneca、 Lundbeck、 Allergan(AbbVie)、 GSK、 Otsuka Pharmaceutical、 Takeda、 Novartis、 Johnson & Johnson、 Eisai、 Kelun Pharmaceutical、 Humanwell Pharmaceutical、 Enhua Pharmaceutical、 Yangzijiang Pharmaceutical
...

This research report provides a comprehensive analysis of the Nervous System Chemicals market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Nervous System Chemicals market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Nervous System Chemicals, challenges faced by the industry, and potential opportunities for market players.
The global Nervous System Chemicals market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Nervous System Chemicals market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Nervous System Chemicals market. Additionally, the growing consumer demand present avenues for market expansion.
The global Nervous System Chemicals market was valued at US$ 75470 million in 2022 and is projected to reach US$ 108040 million by 2029, at a CAGR of 5.3% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Nervous System Chemicals market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Nervous System Chemicals market.
Market Overview: The report provides a comprehensive overview of the Nervous System Chemicals market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Non-prescription Drugs, Prescription), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Nervous System Chemicals market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Nervous System Chemicals market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Nervous System Chemicals market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Nervous System Chemicals market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Nervous System Chemicals market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Nervous System Chemicals market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Nervous System Chemicals, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Nervous System Chemicals market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Nervous System Chemicals market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Non-prescription Drugs
Prescription
Market segment by Application
Hospital
Clinic
Other
Global Nervous System Chemicals Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Pfizer
Ely Lilly
Actavis(Teva Pharmaceuticals)
Mylan(Viatris)
UCB
Intellipharmaceutics
Astrazeneca
Lundbeck
Allergan(AbbVie)
GSK
Otsuka Pharmaceutical
Takeda
Novartis
Johnson & Johnson
Eisai
Kelun Pharmaceutical
Humanwell Pharmaceutical
Enhua Pharmaceutical
Yangzijiang Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nervous System Chemicals, market overview.
Chapter 2: Global Nervous System Chemicals market size in revenue and volume.
Chapter 3: Detailed analysis of Nervous System Chemicals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nervous System Chemicals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Nervous System Chemicals capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Nervous System Chemicals Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nervous System Chemicals Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nervous System Chemicals Overall Market Size
2.1 Global Nervous System Chemicals Market Size: 2022 VS 2029
2.2 Global Nervous System Chemicals Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Nervous System Chemicals Sales: 2018-2029
3 Company Landscape
3.1 Top Nervous System Chemicals Players in Global Market
3.2 Top Global Nervous System Chemicals Companies Ranked by Revenue
3.3 Global Nervous System Chemicals Revenue by Companies
3.4 Global Nervous System Chemicals Sales by Companies
3.5 Global Nervous System Chemicals Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Nervous System Chemicals Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Nervous System Chemicals Product Type
3.8 Tier 1, Tier 2 and Tier 3 Nervous System Chemicals Players in Global Market
3.8.1 List of Global Tier 1 Nervous System Chemicals Companies
3.8.2 List of Global Tier 2 and Tier 3 Nervous System Chemicals Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Nervous System Chemicals Market Size Markets, 2022 & 2029
4.1.2 Non-prescription Drugs
4.1.3 Prescription
4.2 By Type – Global Nervous System Chemicals Revenue & Forecasts
4.2.1 By Type – Global Nervous System Chemicals Revenue, 2018-2023
4.2.2 By Type – Global Nervous System Chemicals Revenue, 2024-2029
4.2.3 By Type – Global Nervous System Chemicals Revenue Market Share, 2018-2029
4.3 By Type – Global Nervous System Chemicals Sales & Forecasts
4.3.1 By Type – Global Nervous System Chemicals Sales, 2018-2023
4.3.2 By Type – Global Nervous System Chemicals Sales, 2024-2029
4.3.3 By Type – Global Nervous System Chemicals Sales Market Share, 2018-2029
4.4 By Type – Global Nervous System Chemicals Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Nervous System Chemicals Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application – Global Nervous System Chemicals Revenue & Forecasts
5.2.1 By Application – Global Nervous System Chemicals Revenue, 2018-2023
5.2.2 By Application – Global Nervous System Chemicals Revenue, 2024-2029
5.2.3 By Application – Global Nervous System Chemicals Revenue Market Share, 2018-2029
5.3 By Application – Global Nervous System Chemicals Sales & Forecasts
5.3.1 By Application – Global Nervous System Chemicals Sales, 2018-2023
5.3.2 By Application – Global Nervous System Chemicals Sales, 2024-2029
5.3.3 By Application – Global Nervous System Chemicals Sales Market Share, 2018-2029
5.4 By Application – Global Nervous System Chemicals Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Nervous System Chemicals Market Size, 2022 & 2029
6.2 By Region – Global Nervous System Chemicals Revenue & Forecasts
6.2.1 By Region – Global Nervous System Chemicals Revenue, 2018-2023
6.2.2 By Region – Global Nervous System Chemicals Revenue, 2024-2029
6.2.3 By Region – Global Nervous System Chemicals Revenue Market Share, 2018-2029
6.3 By Region – Global Nervous System Chemicals Sales & Forecasts
6.3.1 By Region – Global Nervous System Chemicals Sales, 2018-2023
6.3.2 By Region – Global Nervous System Chemicals Sales, 2024-2029
6.3.3 By Region – Global Nervous System Chemicals Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Nervous System Chemicals Revenue, 2018-2029
6.4.2 By Country – North America Nervous System Chemicals Sales, 2018-2029
6.4.3 US Nervous System Chemicals Market Size, 2018-2029
6.4.4 Canada Nervous System Chemicals Market Size, 2018-2029
6.4.5 Mexico Nervous System Chemicals Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Nervous System Chemicals Revenue, 2018-2029
6.5.2 By Country – Europe Nervous System Chemicals Sales, 2018-2029
6.5.3 Germany Nervous System Chemicals Market Size, 2018-2029
6.5.4 France Nervous System Chemicals Market Size, 2018-2029
6.5.5 U.K. Nervous System Chemicals Market Size, 2018-2029
6.5.6 Italy Nervous System Chemicals Market Size, 2018-2029
6.5.7 Russia Nervous System Chemicals Market Size, 2018-2029
6.5.8 Nordic Countries Nervous System Chemicals Market Size, 2018-2029
6.5.9 Benelux Nervous System Chemicals Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Nervous System Chemicals Revenue, 2018-2029
6.6.2 By Region – Asia Nervous System Chemicals Sales, 2018-2029
6.6.3 China Nervous System Chemicals Market Size, 2018-2029
6.6.4 Japan Nervous System Chemicals Market Size, 2018-2029
6.6.5 South Korea Nervous System Chemicals Market Size, 2018-2029
6.6.6 Southeast Asia Nervous System Chemicals Market Size, 2018-2029
6.6.7 India Nervous System Chemicals Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Nervous System Chemicals Revenue, 2018-2029
6.7.2 By Country – South America Nervous System Chemicals Sales, 2018-2029
6.7.3 Brazil Nervous System Chemicals Market Size, 2018-2029
6.7.4 Argentina Nervous System Chemicals Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Nervous System Chemicals Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Nervous System Chemicals Sales, 2018-2029
6.8.3 Turkey Nervous System Chemicals Market Size, 2018-2029
6.8.4 Israel Nervous System Chemicals Market Size, 2018-2029
6.8.5 Saudi Arabia Nervous System Chemicals Market Size, 2018-2029
6.8.6 UAE Nervous System Chemicals Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Nervous System Chemicals Major Product Offerings
7.1.4 Pfizer Nervous System Chemicals Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Ely Lilly
7.2.1 Ely Lilly Company Summary
7.2.2 Ely Lilly Business Overview
7.2.3 Ely Lilly Nervous System Chemicals Major Product Offerings
7.2.4 Ely Lilly Nervous System Chemicals Sales and Revenue in Global (2018-2023)
7.2.5 Ely Lilly Key News & Latest Developments
7.3 Actavis(Teva Pharmaceuticals)
7.3.1 Actavis(Teva Pharmaceuticals) Company Summary
7.3.2 Actavis(Teva Pharmaceuticals) Business Overview
7.3.3 Actavis(Teva Pharmaceuticals) Nervous System Chemicals Major Product Offerings
7.3.4 Actavis(Teva Pharmaceuticals) Nervous System Chemicals Sales and Revenue in Global (2018-2023)
7.3.5 Actavis(Teva Pharmaceuticals) Key News & Latest Developments
7.4 Mylan(Viatris)
7.4.1 Mylan(Viatris) Company Summary
7.4.2 Mylan(Viatris) Business Overview
7.4.3 Mylan(Viatris) Nervous System Chemicals Major Product Offerings
7.4.4 Mylan(Viatris) Nervous System Chemicals Sales and Revenue in Global (2018-2023)
7.4.5 Mylan(Viatris) Key News & Latest Developments
7.5 UCB
7.5.1 UCB Company Summary
7.5.2 UCB Business Overview
7.5.3 UCB Nervous System Chemicals Major Product Offerings
7.5.4 UCB Nervous System Chemicals Sales and Revenue in Global (2018-2023)
7.5.5 UCB Key News & Latest Developments
7.6 Intellipharmaceutics
7.6.1 Intellipharmaceutics Company Summary
7.6.2 Intellipharmaceutics Business Overview
7.6.3 Intellipharmaceutics Nervous System Chemicals Major Product Offerings
7.6.4 Intellipharmaceutics Nervous System Chemicals Sales and Revenue in Global (2018-2023)
7.6.5 Intellipharmaceutics Key News & Latest Developments
7.7 Astrazeneca
7.7.1 Astrazeneca Company Summary
7.7.2 Astrazeneca Business Overview
7.7.3 Astrazeneca Nervous System Chemicals Major Product Offerings
7.7.4 Astrazeneca Nervous System Chemicals Sales and Revenue in Global (2018-2023)
7.7.5 Astrazeneca Key News & Latest Developments
7.8 Lundbeck
7.8.1 Lundbeck Company Summary
7.8.2 Lundbeck Business Overview
7.8.3 Lundbeck Nervous System Chemicals Major Product Offerings
7.8.4 Lundbeck Nervous System Chemicals Sales and Revenue in Global (2018-2023)
7.8.5 Lundbeck Key News & Latest Developments
7.9 Allergan(AbbVie)
7.9.1 Allergan(AbbVie) Company Summary
7.9.2 Allergan(AbbVie) Business Overview
7.9.3 Allergan(AbbVie) Nervous System Chemicals Major Product Offerings
7.9.4 Allergan(AbbVie) Nervous System Chemicals Sales and Revenue in Global (2018-2023)
7.9.5 Allergan(AbbVie) Key News & Latest Developments
7.10 GSK
7.10.1 GSK Company Summary
7.10.2 GSK Business Overview
7.10.3 GSK Nervous System Chemicals Major Product Offerings
7.10.4 GSK Nervous System Chemicals Sales and Revenue in Global (2018-2023)
7.10.5 GSK Key News & Latest Developments
7.11 Otsuka Pharmaceutical
7.11.1 Otsuka Pharmaceutical Company Summary
7.11.2 Otsuka Pharmaceutical Business Overview
7.11.3 Otsuka Pharmaceutical Nervous System Chemicals Major Product Offerings
7.11.4 Otsuka Pharmaceutical Nervous System Chemicals Sales and Revenue in Global (2018-2023)
7.11.5 Otsuka Pharmaceutical Key News & Latest Developments
7.12 Takeda
7.12.1 Takeda Company Summary
7.12.2 Takeda Business Overview
7.12.3 Takeda Nervous System Chemicals Major Product Offerings
7.12.4 Takeda Nervous System Chemicals Sales and Revenue in Global (2018-2023)
7.12.5 Takeda Key News & Latest Developments
7.13 Novartis
7.13.1 Novartis Company Summary
7.13.2 Novartis Business Overview
7.13.3 Novartis Nervous System Chemicals Major Product Offerings
7.13.4 Novartis Nervous System Chemicals Sales and Revenue in Global (2018-2023)
7.13.5 Novartis Key News & Latest Developments
7.14 Johnson & Johnson
7.14.1 Johnson & Johnson Company Summary
7.14.2 Johnson & Johnson Business Overview
7.14.3 Johnson & Johnson Nervous System Chemicals Major Product Offerings
7.14.4 Johnson & Johnson Nervous System Chemicals Sales and Revenue in Global (2018-2023)
7.14.5 Johnson & Johnson Key News & Latest Developments
7.15 Eisai
7.15.1 Eisai Company Summary
7.15.2 Eisai Business Overview
7.15.3 Eisai Nervous System Chemicals Major Product Offerings
7.15.4 Eisai Nervous System Chemicals Sales and Revenue in Global (2018-2023)
7.15.5 Eisai Key News & Latest Developments
7.16 Kelun Pharmaceutical
7.16.1 Kelun Pharmaceutical Company Summary
7.16.2 Kelun Pharmaceutical Business Overview
7.16.3 Kelun Pharmaceutical Nervous System Chemicals Major Product Offerings
7.16.4 Kelun Pharmaceutical Nervous System Chemicals Sales and Revenue in Global (2018-2023)
7.16.5 Kelun Pharmaceutical Key News & Latest Developments
7.17 Humanwell Pharmaceutical
7.17.1 Humanwell Pharmaceutical Company Summary
7.17.2 Humanwell Pharmaceutical Business Overview
7.17.3 Humanwell Pharmaceutical Nervous System Chemicals Major Product Offerings
7.17.4 Humanwell Pharmaceutical Nervous System Chemicals Sales and Revenue in Global (2018-2023)
7.17.5 Humanwell Pharmaceutical Key News & Latest Developments
7.18 Enhua Pharmaceutical
7.18.1 Enhua Pharmaceutical Company Summary
7.18.2 Enhua Pharmaceutical Business Overview
7.18.3 Enhua Pharmaceutical Nervous System Chemicals Major Product Offerings
7.18.4 Enhua Pharmaceutical Nervous System Chemicals Sales and Revenue in Global (2018-2023)
7.18.5 Enhua Pharmaceutical Key News & Latest Developments
7.19 Yangzijiang Pharmaceutical
7.19.1 Yangzijiang Pharmaceutical Company Summary
7.19.2 Yangzijiang Pharmaceutical Business Overview
7.19.3 Yangzijiang Pharmaceutical Nervous System Chemicals Major Product Offerings
7.19.4 Yangzijiang Pharmaceutical Nervous System Chemicals Sales and Revenue in Global (2018-2023)
7.19.5 Yangzijiang Pharmaceutical Key News & Latest Developments
8 Global Nervous System Chemicals Production Capacity, Analysis
8.1 Global Nervous System Chemicals Production Capacity, 2018-2029
8.2 Nervous System Chemicals Production Capacity of Key Manufacturers in Global Market
8.3 Global Nervous System Chemicals Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Nervous System Chemicals Supply Chain Analysis
10.1 Nervous System Chemicals Industry Value Chain
10.2 Nervous System Chemicals Upstream Market
10.3 Nervous System Chemicals Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Nervous System Chemicals Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Nervous System Chemicals in Global Market
Table 2. Top Nervous System Chemicals Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Nervous System Chemicals Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Nervous System Chemicals Revenue Share by Companies, 2018-2023
Table 5. Global Nervous System Chemicals Sales by Companies, (K Units), 2018-2023
Table 6. Global Nervous System Chemicals Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Nervous System Chemicals Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Nervous System Chemicals Product Type
Table 9. List of Global Tier 1 Nervous System Chemicals Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nervous System Chemicals Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Nervous System Chemicals Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Nervous System Chemicals Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Nervous System Chemicals Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Nervous System Chemicals Sales (K Units), 2018-2023
Table 15. By Type - Global Nervous System Chemicals Sales (K Units), 2024-2029
Table 16. By Application – Global Nervous System Chemicals Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Nervous System Chemicals Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Nervous System Chemicals Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Nervous System Chemicals Sales (K Units), 2018-2023
Table 20. By Application - Global Nervous System Chemicals Sales (K Units), 2024-2029
Table 21. By Region – Global Nervous System Chemicals Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Nervous System Chemicals Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Nervous System Chemicals Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Nervous System Chemicals Sales (K Units), 2018-2023
Table 25. By Region - Global Nervous System Chemicals Sales (K Units), 2024-2029
Table 26. By Country - North America Nervous System Chemicals Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Nervous System Chemicals Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Nervous System Chemicals Sales, (K Units), 2018-2023
Table 29. By Country - North America Nervous System Chemicals Sales, (K Units), 2024-2029
Table 30. By Country - Europe Nervous System Chemicals Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Nervous System Chemicals Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Nervous System Chemicals Sales, (K Units), 2018-2023
Table 33. By Country - Europe Nervous System Chemicals Sales, (K Units), 2024-2029
Table 34. By Region - Asia Nervous System Chemicals Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Nervous System Chemicals Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Nervous System Chemicals Sales, (K Units), 2018-2023
Table 37. By Region - Asia Nervous System Chemicals Sales, (K Units), 2024-2029
Table 38. By Country - South America Nervous System Chemicals Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Nervous System Chemicals Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Nervous System Chemicals Sales, (K Units), 2018-2023
Table 41. By Country - South America Nervous System Chemicals Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Nervous System Chemicals Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Nervous System Chemicals Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Nervous System Chemicals Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Nervous System Chemicals Sales, (K Units), 2024-2029
Table 46. Pfizer Company Summary
Table 47. Pfizer Nervous System Chemicals Product Offerings
Table 48. Pfizer Nervous System Chemicals Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Ely Lilly Company Summary
Table 51. Ely Lilly Nervous System Chemicals Product Offerings
Table 52. Ely Lilly Nervous System Chemicals Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Ely Lilly Key News & Latest Developments
Table 54. Actavis(Teva Pharmaceuticals) Company Summary
Table 55. Actavis(Teva Pharmaceuticals) Nervous System Chemicals Product Offerings
Table 56. Actavis(Teva Pharmaceuticals) Nervous System Chemicals Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Actavis(Teva Pharmaceuticals) Key News & Latest Developments
Table 58. Mylan(Viatris) Company Summary
Table 59. Mylan(Viatris) Nervous System Chemicals Product Offerings
Table 60. Mylan(Viatris) Nervous System Chemicals Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Mylan(Viatris) Key News & Latest Developments
Table 62. UCB Company Summary
Table 63. UCB Nervous System Chemicals Product Offerings
Table 64. UCB Nervous System Chemicals Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. UCB Key News & Latest Developments
Table 66. Intellipharmaceutics Company Summary
Table 67. Intellipharmaceutics Nervous System Chemicals Product Offerings
Table 68. Intellipharmaceutics Nervous System Chemicals Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Intellipharmaceutics Key News & Latest Developments
Table 70. Astrazeneca Company Summary
Table 71. Astrazeneca Nervous System Chemicals Product Offerings
Table 72. Astrazeneca Nervous System Chemicals Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Astrazeneca Key News & Latest Developments
Table 74. Lundbeck Company Summary
Table 75. Lundbeck Nervous System Chemicals Product Offerings
Table 76. Lundbeck Nervous System Chemicals Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Lundbeck Key News & Latest Developments
Table 78. Allergan(AbbVie) Company Summary
Table 79. Allergan(AbbVie) Nervous System Chemicals Product Offerings
Table 80. Allergan(AbbVie) Nervous System Chemicals Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Allergan(AbbVie) Key News & Latest Developments
Table 82. GSK Company Summary
Table 83. GSK Nervous System Chemicals Product Offerings
Table 84. GSK Nervous System Chemicals Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. GSK Key News & Latest Developments
Table 86. Otsuka Pharmaceutical Company Summary
Table 87. Otsuka Pharmaceutical Nervous System Chemicals Product Offerings
Table 88. Otsuka Pharmaceutical Nervous System Chemicals Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Otsuka Pharmaceutical Key News & Latest Developments
Table 90. Takeda Company Summary
Table 91. Takeda Nervous System Chemicals Product Offerings
Table 92. Takeda Nervous System Chemicals Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Takeda Key News & Latest Developments
Table 94. Novartis Company Summary
Table 95. Novartis Nervous System Chemicals Product Offerings
Table 96. Novartis Nervous System Chemicals Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Novartis Key News & Latest Developments
Table 98. Johnson & Johnson Company Summary
Table 99. Johnson & Johnson Nervous System Chemicals Product Offerings
Table 100. Johnson & Johnson Nervous System Chemicals Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Johnson & Johnson Key News & Latest Developments
Table 102. Eisai Company Summary
Table 103. Eisai Nervous System Chemicals Product Offerings
Table 104. Eisai Nervous System Chemicals Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Eisai Key News & Latest Developments
Table 106. Kelun Pharmaceutical Company Summary
Table 107. Kelun Pharmaceutical Nervous System Chemicals Product Offerings
Table 108. Kelun Pharmaceutical Nervous System Chemicals Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. Kelun Pharmaceutical Key News & Latest Developments
Table 110. Humanwell Pharmaceutical Company Summary
Table 111. Humanwell Pharmaceutical Nervous System Chemicals Product Offerings
Table 112. Humanwell Pharmaceutical Nervous System Chemicals Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. Humanwell Pharmaceutical Key News & Latest Developments
Table 114. Enhua Pharmaceutical Company Summary
Table 115. Enhua Pharmaceutical Nervous System Chemicals Product Offerings
Table 116. Enhua Pharmaceutical Nervous System Chemicals Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 117. Enhua Pharmaceutical Key News & Latest Developments
Table 118. Yangzijiang Pharmaceutical Company Summary
Table 119. Yangzijiang Pharmaceutical Nervous System Chemicals Product Offerings
Table 120. Yangzijiang Pharmaceutical Nervous System Chemicals Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 121. Yangzijiang Pharmaceutical Key News & Latest Developments
Table 122. Nervous System Chemicals Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 123. Global Nervous System Chemicals Capacity Market Share of Key Manufacturers, 2021-2023
Table 124. Global Nervous System Chemicals Production by Region, 2018-2023 (K Units)
Table 125. Global Nervous System Chemicals Production by Region, 2024-2029 (K Units)
Table 126. Nervous System Chemicals Market Opportunities & Trends in Global Market
Table 127. Nervous System Chemicals Market Drivers in Global Market
Table 128. Nervous System Chemicals Market Restraints in Global Market
Table 129. Nervous System Chemicals Raw Materials
Table 130. Nervous System Chemicals Raw Materials Suppliers in Global Market
Table 131. Typical Nervous System Chemicals Downstream
Table 132. Nervous System Chemicals Downstream Clients in Global Market
Table 133. Nervous System Chemicals Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Nervous System Chemicals Segment by Type in 2022
Figure 2. Nervous System Chemicals Segment by Application in 2022
Figure 3. Global Nervous System Chemicals Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Nervous System Chemicals Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Nervous System Chemicals Revenue, 2018-2029 (US$, Mn)
Figure 7. Nervous System Chemicals Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Nervous System Chemicals Revenue in 2022
Figure 9. By Type - Global Nervous System Chemicals Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Nervous System Chemicals Revenue Market Share, 2018-2029
Figure 11. By Type - Global Nervous System Chemicals Sales Market Share, 2018-2029
Figure 12. By Type - Global Nervous System Chemicals Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Nervous System Chemicals Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Nervous System Chemicals Revenue Market Share, 2018-2029
Figure 15. By Application - Global Nervous System Chemicals Sales Market Share, 2018-2029
Figure 16. By Application - Global Nervous System Chemicals Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Nervous System Chemicals Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Nervous System Chemicals Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Nervous System Chemicals Revenue Market Share, 2018-2029
Figure 20. By Region - Global Nervous System Chemicals Sales Market Share, 2018-2029
Figure 21. By Country - North America Nervous System Chemicals Revenue Market Share, 2018-2029
Figure 22. By Country - North America Nervous System Chemicals Sales Market Share, 2018-2029
Figure 23. US Nervous System Chemicals Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Nervous System Chemicals Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Nervous System Chemicals Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Nervous System Chemicals Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Nervous System Chemicals Sales Market Share, 2018-2029
Figure 28. Germany Nervous System Chemicals Revenue, (US$, Mn), 2018-2029
Figure 29. France Nervous System Chemicals Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Nervous System Chemicals Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Nervous System Chemicals Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Nervous System Chemicals Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Nervous System Chemicals Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Nervous System Chemicals Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Nervous System Chemicals Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Nervous System Chemicals Sales Market Share, 2018-2029
Figure 37. China Nervous System Chemicals Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Nervous System Chemicals Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Nervous System Chemicals Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Nervous System Chemicals Revenue, (US$, Mn), 2018-2029
Figure 41. India Nervous System Chemicals Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Nervous System Chemicals Revenue Market Share, 2018-2029
Figure 43. By Country - South America Nervous System Chemicals Sales Market Share, 2018-2029
Figure 44. Brazil Nervous System Chemicals Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Nervous System Chemicals Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Nervous System Chemicals Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Nervous System Chemicals Sales Market Share, 2018-2029
Figure 48. Turkey Nervous System Chemicals Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Nervous System Chemicals Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Nervous System Chemicals Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Nervous System Chemicals Revenue, (US$, Mn), 2018-2029
Figure 52. Global Nervous System Chemicals Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Nervous System Chemicals by Region, 2022 VS 2029
Figure 54. Nervous System Chemicals Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 神経用化学物質のグローバル市場展望 2023年-2029年：一般用医薬品、処方箋医薬品(Nervous System Chemicals Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

神経用化学物質のグローバル市場展望 2023年-2029年：一般用医薬品、処方箋医薬品

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp